Advertisement
Table 2 Motor nerve conduction measurements
| group | Pre-chemotherapy | Post-chemotherapy* | p-value # | |
|---|---|---|---|---|
| Tibial nerve | ||||
| DML(ms) | Omega 3 | 16.53 (1.95) | 17.59 (2.21) | .870 |
| Placebo | 17.00 (2.16) | 17.80 (3.10) | ||
| a-CMAP(mV) | Omega 3 | 10.00 (5.18) | 11.18 (6.35) | .149 |
| Placebo | 11.38 (6.08) | 10.68 (5.80) | ||
| MCV(m/s) | Omega 3 | 46.38 (3.67) | 45.16 (4.24) | .359 |
| Placebo | 46.24 (5.08) | 46.03 (6.65) | ||
| Peroneal nerve | ||||
| DML(ms) | Omega 3 | 14.16 (1.80) | 14.97 (2.53) | .209 |
| Placebo | 14.85 (3.18) | 14.91 (2.37) | ||
| a-CMAP(mV) | Omega 3 | 6.20 (6.68) | 4.43 (3.26) | .549 |
| Placebo | 5.51 (3.41) | 3.83 (3.15) | ||
| MCV(m/s) | Omega 3 | 46.13 (3.32) | 45.87 (4.75) | .106 |
| Placebo | 46.46 (5.24) | 42.38 (9.90) | ||
| Ulnar nerve | ||||
| DML(ms) | Omega 3 | 9.48 (.74) | 9.67 (.86) | .439 |
| Placebo | 9.67 (.98) | 9.60 (1.29) | ||
| a-CMAP(mV) | Omega 3 | 17.29 (12.95) | 14.25 (3.79) | .256 |
| Placebo | 13.80 (3.53) | 13.29 (4.73) | ||
| MCV(m/s) | Omega 3 | 57.30 (5.18) | 55.82 (6.35) | .706 |
| Placebo | 55.80 (4.90) | 53.19 (7.29) |
